3

OWNERSHIP DOCUMENT

Company: Acumen Pharmaceuticals, Inc.
Filed: June 30, 2021
Period of Report: June 30, 2021
Accession Number: 0001104659-21-087732

View Document ↗ View on SEC.gov ↗